← Leaderboards
Anne Neilan
Massachusetts General Hospital
$4,903,623
Attributed
$4,903,623
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,903,623 · 2
By mechanism
R01$3,967,474 · 1
K08$936,149 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Beth Ann Stevens$21,074,664
- Conall Michael O'Cleirigh$14,994,576
- Michael V. Seiden$17,220,467
- Jonathan P Winickoff$16,869,989
- Alexander Gabriel Fiks$8,533,248
Others in their field
Other Emerging Leaders on “Adolescent And Young Adult”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$91,052,672
- Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr$16,660,001
- Cecile Feldman · Rbhs-School Of Dental Medicine$11,278,781
- John E Schulenberg · University Of Michigan At Ann Arbor$10,169,002
- Angela Ramona Branche · University Of Rochester$10,119,005
- Elizabeth Fox · St. Jude Children'S Research Hospital$8,840,232
Research focus
Adolescent And Young AdultModels And SimulationPharmaceutical PreparationsCost EffectivenessAdherencePoliciesModalityFutureInfectionPre-Exposure ProphylaxisAffectClinical ResearchFoundationsClinical TrialsNational Institute Of Child Health And Human DevelopmentCost Effectiveness AnalysisHiv InfectionsAids PreventionCaringAntiretroviral TherapyEpidemicDiagnosisBehaviorPrevent
Grant awards (12)
Adolescent-tailored HIV treatment and prevention strategies in South Africa: projecting clinical benefits and value$932,301
R01 · FY2025 · HD · contact PI
Adolescent-tailored HIV treatment and prevention strategies in South Africa: projecting clinical benefits and value$197,304
R01 · FY2025 · HD · contact PI
Adolescent-tailored HIV treatment and prevention strategies in South Africa: projecting clinical benefits and value$794,520
R01 · FY2024 · HD · contact PI
Adolescent-tailored HIV treatment and prevention strategies in South Africa: projecting clinical benefits and value (Supplement)$419,752
R01 · FY2024 · HD · contact PI
Adolescent-tailored HIV treatment and prevention strategies in South Africa: projecting clinical benefits and value$792,840
R01 · FY2023 · HD · contact PI
Diagnosing and preventing HIV infection in adolescents and young adults in the US: clinical impact and cost-effectiveness$74,551
K08 · FY2023 · HD · contact PI
Adolescent-tailored HIV treatment and prevention strategies in South Africa: projecting clinical benefits and value$830,757
R01 · FY2022 · HD · contact PI
Diagnosing and preventing HIV infection in adolescents and young adults in the US: clinical impact and cost-effectiveness$172,800
K08 · FY2022 · HD · contact PI
Diagnosing and preventing HIV infection in adolescents and young adults in the US: clinical impact and cost-effectiveness$172,800
K08 · FY2021 · HD · contact PI
Diagnosing and preventing HIV infection in adolescents and young adults in the US: clinical impact and cost-effectiveness$171,981
K08 · FY2020 · HD · contact PI
Diagnosing and preventing HIV infection in adolescents and young adults in the US: clinical impact and cost-effectiveness$171,981
K08 · FY2019 · HD · contact PI
Diagnosing and preventing HIV infection in adolescents and young adults in the US: clinical impact and cost-effectiveness$172,036
K08 · FY2018 · HD · contact PI